Vor Biopharma (VOR) Capital Expenditures (2020 - 2026)
Vor Biopharma (VOR) reported Capital Expenditures of $12000.0 for Q1 2026, down 98.68% on a QoQ basis from $912000.0 in Q4 2025.
Vor Biopharma (VOR) has 7 years of Capital Expenditures data on file, last reported at $12000.0 in Q1 2026.
- Quarterly Capital Expenditures changed N/A year-over-year to $12000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $953000.0 (up 728.7% YoY) and the FY2025 annual result came in at $941000.0, up 310.92% from the prior year.
- Capital Expenditures declined to $12000.0 in Q1 2026 per VOR's latest filing, from $912000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $3.5 million in Q1 2022 and bottomed at -$2.2 million in Q2 2022.
- The 5-year median for Capital Expenditures is $10500.0 (2024), against an average of $80625.0.
- Peak annual rise in Capital Expenditures reached 4155.56% in 2025, while the deepest fall reached 1141.18% in 2025.
- Tracing VOR's Capital Expenditures over 5 years: stood at -$18000.0 in 2022, then soared by 138.89% to $7000.0 in 2023, then soared by 928.57% to $72000.0 in 2024, then jumped by 1166.67% to $912000.0 in 2025, then slumped by 98.68% to $12000.0 in 2026.
- Per Business Quant, the three latest VOR Capital Expenditures figures stand at $12000.0 (Q1 2026), $912000.0 (Q4 2025), and -$354000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Vor Biopharma | 628.83 Mn | 628.83 Mn | - | 12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 912,000.00 |
| Dec 31, 2025 | 912,000.00 |
| Sep 30, 2025 | -354,000.00 |
| Sep 30, 2025 | -354,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | -430,000.00 |
| Sep 30, 2023 | -430,000.00 |
| Jun 30, 2023 | 490,000.00 |
| Jun 30, 2023 | 490,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | -18,000.00 |
| Dec 31, 2022 | -18,000.00 |
| Sep 30, 2022 | -1.28 Mn |
| Sep 30, 2022 | -1.28 Mn |
| Jun 30, 2022 | -2.21 Mn |
| Jun 30, 2022 | -2.21 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 636,000.00 |
| Sep 30, 2021 | 636,000.00 |
| Jun 30, 2021 | 1.94 Mn |
| Jun 30, 2021 | 1.94 Mn |
| Mar 31, 2021 | 149,000.00 |
| Mar 31, 2021 | 149,000.00 |
| Dec 31, 2020 | -2.24 Mn |
| Dec 31, 2020 | -2.24 Mn |
| Sep 30, 2020 | 1.59 Mn |
| Sep 30, 2020 | 1.59 Mn |
| Jun 30, 2020 | 552,000.00 |
| Jun 30, 2020 | 552,000.00 |
| Mar 31, 2020 | 545,000.00 |
| Mar 31, 2020 | 545,000.00 |